# BioMarin Pharmaceutical, Inc. – FDA 483, Jun 9, 2026

Source: https://www.keypedia.com/records/483/biomarin-pharmaceutical-inc/3d9f6c03-46e4-4018-9f28-eb0298368c73

> FDA 483 for BioMarin Pharmaceutical, Inc. on June 09, 2026. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: BioMarin Pharmaceutical, Inc.
- Inspection Date: 2026-06-09
- Product Type: biologics
- Office Name: San Francisco District Office
- Summary: BioMarin Pharmaceutical, Inc. in Novato, CA, received a Form 483 citing significant deficiencies across its API Biotech Drug manufacturing operations. Observations include inadequate quality oversight with persistently failing analytical methods, poor facility maintenance, and insufficient equipment requalification. Additionally, the firm failed to implement proper corrective actions, exhibited deficient microbial control, and had inadequate lifetime validation for chromatography resins and manufacturing process controls.

## Related Documents

- [483 - 2024-08-19](https://www.keypedia.com/records/483/biomarin-pharmaceutical-inc/59238adc-e27c-4c98-954a-e756c73ea1ea) — date: August 19, 2024
- [483 - 2021-04-02](https://www.keypedia.com/records/483/biomarin-pharmaceutical-inc/68119bf5-5042-4336-9c03-7fde3f113010) — date: April 2, 2021
- [EIR - 2021-04-02](https://www.keypedia.com/records/eir/biomarin-pharmaceutical-inc/1d79f65a-b3d4-47d3-b05d-e2df9c3252df) — date: April 2, 2021
- [483 - 2020-05-28](https://www.keypedia.com/records/483/biomarin-pharmaceutical-inc/1e97f714-134a-473e-8ca8-bbb33d74dfd1) — date: May 28, 2020
- [EIR - 2018-11-09](https://www.keypedia.com/records/eir/biomarin-pharmaceutical-inc/d68114e4-98af-4ad9-9a84-ee2c914e8a3a) — date: November 9, 2018

## Related Officers

- [Public Affairs Specialist](https://www.keypedia.com/people/joey-v-quitania/faae874f-94ea-4b63-89d1-649e60726f6f)
- [Matthew R. Clabeaux](https://www.keypedia.com/people/matthew-r-clabeaux/9acc9b47-4063-4582-ac9a-983a07079495)
- [ analyst /Microbiologist ](https://www.keypedia.com/people/ana-maria-a-plapcianu/5f370fbd-8ff9-4fcf-ad57-380201abc7cd)
- [Mercy Oyugi](https://www.keypedia.com/people/mercy-oyugi/9da8ebdc-a4c6-4666-9096-9a17f4edcf6c)
- [Esther C. Broner](https://www.keypedia.com/people/esther-c-broner/5df7ca72-a21f-4586-a5e0-8a782045281c)

Company: https://www.keypedia.com/companies/biomarin-pharmaceutical-inc/7811b401-4321-4df1-b9b5-deef8905c101

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df